Agoracom Blog Home

Posts Tagged ‘weed’

« Older Entries
Newer Entries »

Spyder #Cannabis $SPDR.ca – An Analysis of Canadian Cannabis Sales Growth $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:55 PM on Thursday, September 5th, 2019

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

(TSX-V: SPDR)

Canadian Cannabis Sales Growth: An Analysis

  • Statistics Canada released June data on cannabis retail sales last week. Nationwide, June retail sales hit $91.1M, which implies an annual run-rate of $1.1B in cannabis sales across Canada.

By: SmallCapPower

Statistics Canada reported that Canadian cannabis sales on a retail level for June continue to show growth across Canada, driven by new retail locations in Ontario, British Columbia, and Alberta

In Canada, unadjusted sales of cannabis in stores have grown by 120% between October 2018 and June 2019 (Figure 1). In our opinion, recreational cannabis sales are set to continue growing with the upcoming legalization of edibles expected in October 2019. With the increasing demand for cannabis products, there are concerns for Canada’s ability to avoid a supply shortage. For instance, Ontario, the most populous province in Canada, currently has 25 retail locations (plans to increase to 67 by October 2019). As it is a heavily-concentrated area for cannabis companies, with Canopy Growth and Aphria being headquartered in the province, there is the largest demand for cannabis at about 2.9M users. We believe that there are currently not enough retailers to meet demand and as more retailers come on-line,  nationwide sales are expected to increase.

Figure 1: Statistics Canada: Cannabis Legal Retail Sales

Source: Statistics Canada, Ubika

Based on Statistics Canada’s June retail sales data, retail sales are at the highest level since legalization back in October 2018 and have reached an annualized run-rate of $1.1B. Retail sales grew 6% month-over-month (MoM), a decrease of 900 basis points from the prior month. By our estimates this represents ~20% legal market penetration of the illicit market, as Statistics Canada reported that in 2018 total sales of cannabis in Canada totalled ~$6B.

Figure 2: Statistics Canada: Sales Figures by Province

Source: Statistics Canada, Ubika

There was an initial bump in retail sales in April 2019, which coincided with new store openings nationwide particularly in Ontario, but that growth seems to have tapered off in June. Notably, Ontario, Quebec, Alberta, and British Columbia have seen MoM growth of 13%, 8%, 5%, and 18%, respectively, driven by 69 new brick-and-mortar retail locations opening from April to June (24 in Ontario, 2 in Quebec, 30 in Alberta, and 13 in British Columbia). Retail sales are expected to continue to increase as additional retail stores are added, particularly in Ontario. Currently, Ontario has approximately 1 store per 115,000 people, compared with Alberta, which has 1 store for every 10,000 people. Ontario has ~740 liquor stores (1 store/20,000 people) and Alberta has ~875 liquor stores (1 store/5000 people). We are of the opinion that Ontario could support ~1,500 cannabis retail stores, which would bring store saturation to ~1 store/10,000 people. Going into the second half of 2019, we expect steady growth in store openings, in particular Ontario, where the OCS has announced the 42 winners of the cannabis retail lottery, which will bring the total number of retail locations in Ontario to 67. This highlights that with an already underserved market, the provinces will have to start increasing the number retail locations per province to satisfy demand.

Source: https://smallcappower.com/news/market-news/canadian-cannabis-sales-growth/

Tags: , , , , , , , , ,
Posted in Spyder Cannabis Inc. | Comments Off on Spyder #Cannabis $SPDR.ca – An Analysis of Canadian Cannabis Sales Growth $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Spyder Cannabis $SPDR.ca Continues US Expansion through Specialty License Agreement in Florida with Palm Beach Outlets $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 12:02 PM on Thursday, September 5th, 2019
  • Opening boutique retail locations in Palm Beach Outlets
  • Located just off the I-95, on Palm Beach Lakes Blvd in West Palm Beach, this location will expand Spyder’s physical footprint to a projected 12 total locations by the end of this year
  • Potential for additional locations in the future.

Vaughan, Ontario–(September 5, 2019) – Spyder Cannabis Inc. (“Spyder“), an established Canadian cannabis supply and vape retailer, announced today an arrangement through which Spyder will open boutique retail locations in Palm Beach Outlets.

Located just off the I-95, on Palm Beach Lakes Blvd in West Palm Beach, this location will expand Spyder’s physical footprint to a projected 12 total locations by the end of this year, with the potential for additional locations in the future. Spyder will offer first-class retail sale of products of the highest quality and as permitted by the governing laws of the State of Florida. Products will be limited to oils, lotions, bath products and candies.

“Palm Beach outlets is one of the highest traffic outlet malls in Florida, has received many retail awards and has 100 + brand stores with Whole Foods as an anchor tenant,” stated Daniel Pelchovitz, CEO and President of Spyder. “This move is part of Spyder’s strategic plan to develop a robust, planned network of boutique retail stores and kiosks across the US focused on the specific health and wellness aging and athletics sectors.”

Spyder intends on partnering with a variety of developers and realtors to sign lease agreements for prime real estate in strategically located in high traffic areas of malls, near senior living centres, and sporting venues throughout the U.S. starting in Florida, California, New York and Michigan state. These boutiques will stock Spyder’s SPDR (R) branded and infused products developed for an aging, health and wellness demographic. Spyder will offer a wide array of product offerings including; muscle balm, face oil, body lotion and bath salts, as well as wellness tinctures, capsules and sprays.

About Spyder Cannabis

Founded in 2014 Spyder is an established chain of three high-end vape stores, and two cannabis accessory stores, in Ontario, with locations in Woodbridge, Scarborough, Burlington, Pickering and Niagara Falls. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with plans to create a significant footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. boutique retail and kiosks in high traffic peripheral areas

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Contact: Investor Relations
Phone: 1-888-504-SPDR (1-888-504-7737)
Email: [email protected]

Bullseye Corporate
Crystal Quast
Bullseye Corporate
[email protected]

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur..

These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Any number of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47560

Tags: , , , , , , , ,
Posted in Featured, Spyder Cannabis Inc. | Comments Off on Spyder Cannabis $SPDR.ca Continues US Expansion through Specialty License Agreement in Florida with Palm Beach Outlets $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

VIDEO: NORTHBUD $NBUD.ca Provides September Update – Submits Evidence Package to Health Canada $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 9:00 AM on Tuesday, September 3rd, 2019

The summer was busy for NORTHBUD, as the company completed the facility and submitted evidence package to Health Canada.

NORTHBUD September Update from NORTHBUD on Vimeo.

Hub On AGORACOM

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on VIDEO: NORTHBUD $NBUD.ca Provides September Update – Submits Evidence Package to Health Canada $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Bougainville Ventures Inc $BOG.ca – #Hemp industry awaits new #USDA rules $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:59 AM on Thursday, August 29th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Hemp industry awaits new USDA rules

  • Hemp was decriminalized in the 2018 Farm Bill thanks to legislation sponsored by Wyden, fellow Oregon Democrat Jeff Merkley and Senate Majority Leader Mitch McConnell, R-Ky.
  • Wyden addressed the state of the hemp industry during a panel discussion Aug. 19 at the Western U.S. Hemp Growers Conference and Expo in Portland. He said Oregon is “at the epicenter of the enormous potential for the hemp in the country.”

By GEORGE PLAVEN

PORTLAND — New rules for growing and testing hemp are coming this fall from the USDA, and that has farmers anxious about establishing consistent standards for the booming crop.

U.S. Sen. Ron Wyden, D-Ore., said the agency expects to issue regulations in the next two to four weeks.

Hemp was decriminalized in the 2018 Farm Bill thanks to legislation sponsored by Wyden, fellow Oregon Democrat Jeff Merkley and Senate Majority Leader Mitch McConnell, R-Ky.

Wyden addressed the state of the hemp industry during a panel discussion Aug. 19 at the Western U.S. Hemp Growers Conference and Expo in Portland. He said Oregon is “at the epicenter of the enormous potential for the hemp in the country.”

“We have an enormous sense of pride with the incredible growth in this industry, virtually overnight,” Wyden said.

Since 2014, the state has gone from 13 registered hemp growers and 105 acres to 1,883 growers and roughly 62,000 acres, according to the Oregon Department of Agriculture.

The Hemp Farming Act of 2018 that passed Congress with bipartisan support — led by unlikely allies in Wyden, Merkley and McConnell — classified hemp as an agricultural commodity.

“I think it’s pretty obvious you are on the right side of history,” Wyden told the crowd gathered for the conference. “You don’t have thousands of farmers moving into this space for nothing.”

Hemp, like marijuana, is a cannabis plant, though it legally contains less than 0.3% tetrahydrocannabinol, or THC, the main ingredient that gets users high.

While hemp fiber can be used to make paper, textiles, clothing and building materials such as “hempcrete,” the current primary market is for products containing a derivative extract known as cannabidiol, or CBD. Companies are putting CBD in everything from cosmetics to beverages, touting numerous benefits.

The USDA Agricultural Marketing Service is now developing a program to implement the Hemp Farming Act, which requires states and tribes as the primary regulators of hemp to comply with federal standards for testing THC levels, inspecting farms and monitoring overall production.

States will submit their detailed plans for approval once the regulations are announced, going into effect for the 2020 planting season.

Sunny Summers, cannabis policy coordinator for ODA, said Oregon already does testing and tracks production under the state’s hemp pilot program. Such pilot programs were permitted by the 2014 Farm Bill.

“This is not anything new,” Summers said. “We should be setting the standard for the country.”

The goal, Summers said, is to begin treating hemp the same as any other crop. But she said the industry still has challenges ahead, pointing to issues such as the potential for cross-pollination of crops, pesticide drift and managing odor.

“Coexistence is the backbone of Oregon agriculture,” Summers said. “The industry is going to have to come together and find those opportunities to coexist.”

Courtney Moran, a hemp lobbyist and president of the Oregon Industrial Hemp Farmers Association, said the USDA rules should clarify uncertainties for hemp growers and producers around interstate commerce, banking, crop insurance and law enforcement.

“No matter where you’re going, we want to make sure crops are legal and compliant,” Moran said.

The Food and Drug Administration is responsible for regulating and classifying CBD products. Wyden said he was told that could take three to five more years, which he pushed back against forcefully.

The government is starting to make progress implementing the Hemp Farming Act, Wyden said, but needs to move faster.

“CBD products have enormous potential. And that was the whole purpose of the bill,” Wyden said. “We don’t want to see that potential squelched because the feds are moving too slowly.”

Source: https://www.capitalpress.com/state/oregon/hemp-industry-awaits-new-usda-rules/article_81fc61ac-c2b6-11e9-8c1b-eb5e8365b360.html

Tags: , , , , , ,
Posted in All Recent Posts, Bougainville Ventures | Comments Off on Bougainville Ventures Inc $BOG.ca – #Hemp industry awaits new #USDA rules $CROP.ca $VP.ca NF.ca $MCOA

Spyder #Cannabis $SPDR.ca – Alberta squeaks out title as Canada’s top cannabis market with $123.6M sold $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 10:16 AM on Thursday, August 29th, 2019

SPONSOR: Spyder Cannabis (SPDR:TSXV) went public just a couple of months ago and hit the ground running with 5 operating Canadian retail locations – and a 6th one on the way via an 8,000 sq ft super store in Alberta.  Most companies would be ecstatic to have this number of locations – but Spyder just announced a major move into the United States, with a 5 location deal for boutique stores up and down the US Eastern seaboard.  The news gets better.  If all goes well with these 5 locations, the US outlet partner has a total of 39 locations across 20 states for Spyder to grow into to. Click here for more info.

(TSX-V: SPDR)

Alberta squeaks out title as Canada’s top cannabis market with $123.6M sold

Ontario, Quebec not far behind in new data showing sales since legalization

Rachel Ward

Gord Nichol shows off some of the products he bought inside RELM Cannabis Co., in Burlington, Ont. on April 1. Alberta narrowly squeaked out as Canada’s top cannabis market, surpassing Ontario by a matter of a few million. (Dan Taekema/CBC)

  • Albertans pull out their wallets for legal weed more often than other Canadians, new data shows.
  • Statistics Canada has published new information on the amount sold at cannabis store across the country, from legalization in October 2018 to June 2019.

The sales data shows that Alberta comes out as the top legal cannabis market in Canada, with more than $123.6 million in sales.

Alberta narrowly squeaked into the top spot with Ontario close behind at $121.6 million, followed by Quebec at $119.2 million.

‘Best job of any province,’ retailer says

Alberta’s quick pick-up in the cannabis market can be attributed to the province’s regulator â€” Alberta Gaming Liquor and Cannabis (AGLC) — argues Darren Bondar, who runs a national chain of cannabis stores out of Calgary.

“Alberta and the AGLC have done the best job of any province in the country,” the Spirit Leaf CEO said.

He notes AGLC had experience with private liquor stores, which helped them co-ordinate the opening of 275 private cannabis vendors.

The province also runs a public website that sells and mails out cannabis products.

Ontario may soon surpass Alberta in sales, however. The province was slow in getting stores open but expects to see another 50 open this fall.

Another of Canada’s most populous provinces, British Columbia, saw slow sales, coming ninth on the list. Smaller provinces of Nova Scotia and New Brunswick, saw more money spent.

Canada’s first cannabis competition

Alberta can also boast the country’s first legal cannabis competition when Hempfest Expo opens this October in Calgary. A big draw for other international cannabis hotspots, like Colorado and Amsterdam, expectations for Hempfest Cup are high.

The competition runs Oct. 11-12 at Stampede Park, and will boast entries from big and little growers alike â€” even Canadians who are (legally) growing plants in their homes or yards. Registration for the event closes Sept. 12.

Source: https://www.cbc.ca/news/canada/calgary/alberta-cannabis-sales-1.5259452

Tags: , , , , , , , , ,
Posted in All Recent Posts, Featured, Spyder Cannabis Inc. | Comments Off on Spyder #Cannabis $SPDR.ca – Alberta squeaks out title as Canada’s top cannabis market with $123.6M sold $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Spyder $SPDR.ca Announces Proposed Acquisition of Development Permit and Lease $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:39 AM on Thursday, August 29th, 2019
  • Entered into a purchase agreement with an arm’s length third party to acquire the Vendor’s interest in a development permit issued by the City of Calgary for the operation of a retail cannabis store and an assignment of the leased attached to such Development Permit

Vaughan, Ontario–(August 29, 2019) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“), an established Ontario retail operator, is pleased to announced it has entered into a purchase agreement (the “Agreement“) with an arm’s length third party (the “Vendor“) to acquire the Vendor’s interest in a development permit issued by the City of Calgary for the operation of a retail cannabis store (the “Development Permit“) and an assignment of the leased attached to such Development Permit (the “Lease Assignment“; together with the Development Permit, the “DP Assets“).

Pursuant to the Agreement, the purchase price for the DP Assets will be $175,000, which will be payable through the issuance of 3,000,000 common shares of Spyder (“Spyder Shares“) at a deemed price of $0.0583 per share. The closing of the transactions contemplated by the Agreement is subject to the satisfaction of a number of conditions, including, but not limited to, receipt of all required regulatory approvals including the approval of the TSX Venture Exchange, the Company’s satisfaction of its due diligence results, inspections and investigations and obtaining landlord’s consent to the Lease Assignment.

About Spyder

Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis market. Spyder has developed a scalable retail model with aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian locations in high traffic peripheral areas.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the satisfaction of the closing conditions contemplated under the Agreement. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company. Risk factors that could cause actual results or outcomes to differ materially from the results expressed or implied by forward-looking information include, among other things: the TSX Venture Exchange declining to accept the transaction, the landlord not consenting to the Lease Assginment, changes in tax laws, general economic and business conditions; and changes in the regulatory regulation. The Company cautions the reader that the above list of risk factors is not exhaustive. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer 
Telephone: (905) 265-8273
Email: [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47380

Tags: , , , , , , , , ,
Posted in Featured, Spyder Cannabis Inc. | Comments Off on Spyder $SPDR.ca Announces Proposed Acquisition of Development Permit and Lease $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

CLIENT FEATURE: Empower Clinics $CBDT.ca – 165,000 Patients Already, CBDT Is Positioned To Become A Medical #Cannabis & #CBD Retail Powerhouse $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 12:14 PM on Wednesday, August 28th, 2019

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025

Recent Acquisition of Sun Valley Certification Clinics Holdings LLC

  • Created one of the largest clinic groups in the medical cannabis sector in the United States
  • Twelve (combined) clinic locations
  • Operating in Washington, Oregon, Arizona, Nevada and California

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: Empower Clinics is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Empower Clinics Inc., Featured | Comments Off on CLIENT FEATURE: Empower Clinics $CBDT.ca – 165,000 Patients Already, CBDT Is Positioned To Become A Medical #Cannabis & #CBD Retail Powerhouse $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

EMPOWER CLINICS $CBDT.ca – Rob Gronkowski Announces New Line Of #CBD Products, Leaves Door Open For Return To Football $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 11:21 AM on Tuesday, August 27th, 2019

SPONSOR: EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt: 8EC) (OTC: EPWCF)

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
—————-

Rob Gronkowski Announces New Line Of CBD Products, Leaves Door Open For Return To Football

  • Rob Gronkowski’s “next chapter” involves a campaign to get professional sports leagues to loosen their restrictions on CBD products.
  • Retired former Patriots tight end announced at a press conference in New York City on Tuesday that he has partnered with Abacus Health to launch a line of CBD products, after Gronkowski said the products changed his life.

BOSTON (CBS) — Rob Gronkowski’s “next chapter” involves a campaign to get professional sports leagues to loosen their restrictions on CBD products.

The retired former Patriots tight end announced at a press conference in New York City on Tuesday that he has partnered with Abacus Health to launch a line of CBD products, after Gronkowski said the products changed his life.

“I immediately made CBDMedic part of my recovery,” Gronkowski said of his post-retirement treatment. “And now for the first time in more than a decade, I am pain-free. And that is a big deal.”

Citing his countless injuries and his nine surgeries during his playing career, Gronkowski said he had no choice but to retire.

“[The injuries] took an absolute beating on my mind and my soul. I was hurt both mentally and physically, day in and day out,” Gronkowski said. “I decided to walk away from the game for one reason: I had to recover.”

Gronkowski said his own results have led to him choosing to make a plea to professional sports leagues to allow active players to use CBD products to treat their own injuries.

“It’s just time,” he said.

Gronkowski was asked the question that’s been asked by everyone and anyone over the past few months: Is he returning to the NFL? Gronkowski got emotional when answering the question.

“It’s crazy. I understand. I feel that love. But I want to be clear to my fans: I needed to recover. I was not in a good place. Football was bringing me down. And I didn’t like it. And I was losing that joy in life. Like, the joy. I’m sorry right now,” Gronkowski said, fighting through tears. “But … I really was. And I was fighting through it. And I knew what I signed up for and I knew what I was fighting through, and I knew I just needed to fix myself.”

Gronkowski said his focus now is on achieving optimal health, and that a return to the NFL is not in the cards in the coming weeks or the next month.

However, Gronkowski left the door open to a return to playing football, if he feels healthy enough at a later date.

“I truly believe I can get to another level with my body, and I’m just in the first stage right now,” Gronkowski shared. “When that time comes down in the future, if I have the desire to play football again, if I feel passionate about football again, if I’m feeling like I need to go back on the field, I will go back to football. But as of right now, that is not the case. It could be the case in six months, it could be the case in two years, it could be the case in three years, it could be the case in three months. But I truly don’t see it in the foreseeable future, in like a week or a month. No. I want to do a different chapter of my life right now.”

Gronkowski shared a personal story about the types of injuries he played through, discussing a hit to his quad he endured during a Super Bowl. Gronkowski finished the game and won a championship, but that was jut the start of the pain.

“I was in tears in my bed after a Super Bowl victory. … It didn’t make much sense to me,” Gronkowski said. “I couldn’t sleep for more than 20 minutes a night, after a Super Bowl win. And I was like damn, this sucks. It didn’t feel right.”

Gronkowski said that in three separate hospital visits, 1000 milliliters of blood was drained from his leg.

“It’s not normal. It was like record-breaking at the hospital,” Gronkowski said. “I was like, you know I like to break records — which I do, I think I broke records on and off the field non-stop, with injuries and everything. That’s what I do.”

Tuesday’s press conference was initially announced on Aug. 13, immediately leading to speculation regarding what Gronkowski’s “next chapter” might be.

Gronkowski, who turned 30 in May, retired from football after completing his ninth season. He was originally drafted in the second round of the 2010 draft by the Patriots, for whom he caught 521 passes for 7,861 yards and 79 touchdowns during his Hall of Fame career. He also added 81 playoff receptions for 1,163 yards and 12 touchdowns in 16 games played, helping the Patriots to wins in both Super Bowl XLIX and LIII.

Talk of a potential Gronkowski retirement began during the offseason prior to the 2018 season, but Gronkowski ultimately decided to play. He announced his retirement in late March of this year, after making a diving catch to set up the game-winning touchdown in Super Bowl LIII against the Rams.

Gronkowski also announced a new name for himself.

“Now, you can just call me Mr. Recovery,” Gronkowski said. “You know you like that name. Mr. Recovery, baby!

Source:  https://boston-cbslocal-com.cdn.ampproject.org/v/s/boston.cbslocal.com/2019/08/27/rob-gronkowski-cbd-products-return-to-football/amp/?usqp=mq331AQEKAFwAQ%3D%3D&amp_js_v=0.1#aoh=15669175021737&referrer=https%3A%2F%2Fwww.google.com&amp_tf=From%20%251%24s&ampshare=https%3A%2F%2Fboston.cbslocal.com%2F2019%2F08%2F27%2Frob-gronkowski-cbd-products-return-to-football%2F

Tags: , , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on EMPOWER CLINICS $CBDT.ca – Rob Gronkowski Announces New Line Of #CBD Products, Leaves Door Open For Return To Football $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

CLIENT FEATURE: Newly Listed Spyder #Cannabis $SPDR.ca Scores 5 US Retail Locations, With Possibility To Expand To 39, With US Outlet Partner $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 9:15 PM on Sunday, August 25th, 2019

WHY SPYDER CANNABIS?

  • Targeted and disciplined retail distribution strategy focusing on high quality, high traffic peripheral areas
  • Focused strategy aimed at vertical, horizontal and geographic diversification with demonstrated operations expertise and proven retail roll-out
  • Opened two additional stores in July for a total of 5 locations (11 by end of year)
  • Signed its first hemp agreement for the supply of full spectrum products to support Spyder’s debut of a hemp infused product line to be sold across the U.S. under its SPDR(R) brand
  • Received approval of development permit for a flagship cannabis retail location in the heart of Calgary

Signed Retail Agreement with Tanger Outlet, Gaining Access to Millions of Consumers Coast-to-Coast in the U.S.

  • Announced an arrangement through which Spyder will open 5 hemp boutique locations with potential for more at Tanger Outlet centers throughout the United States
  • Agreement will expand Spyder’s physical footprint to a projected 11 total locations by the end of this year, with the potential for additional locations in the future
  • Tanger Outlet operates 39 upscale outlet shopping centers located in 20 states coast to coast and will allow us access to millions of consumers

WATCH OUR RECENT INTERVIEW

FULL DISCLOSURE: Spyder Cannabis is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Spyder Cannabis Inc. | Comments Off on CLIENT FEATURE: Newly Listed Spyder #Cannabis $SPDR.ca Scores 5 US Retail Locations, With Possibility To Expand To 39, With US Outlet Partner $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

INTERVIEW: With 165,000 Patients Already, $CBDT.ca Is Positioned To Become A Medical #Cannabis & #CBD Retail Killer … But It Doesn’t End There $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 6:07 PM on Thursday, August 22nd, 2019

At 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Add in the fact it is now on a ~ $USD 4,000,000 annualized revenue run rate for 2019 and it becomes the kind of company small cap investors have been dying to find.  

But it doesn’t end there.    

The Company is set to expand rapidly by taking its proven model into the franchise world for rapid expansion across the USA, with 4 applications already received in the last 30 days, as well as, launch its CBD extraction facility with an initial capacity of 6,000 Kg per year.   But it doesn’t end there.  

The Company’s new CEO, Steven McAuley, who replaced the previous management team in January, is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never.  

Grab your favourite cold beverage here in hot August and settle in for what may be your next great small cap investment.

Tags: , , , , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Empower Clinics Inc., Featured | Comments Off on INTERVIEW: With 165,000 Patients Already, $CBDT.ca Is Positioned To Become A Medical #Cannabis & #CBD Retail Killer … But It Doesn’t End There $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

« Older Entries
Newer Entries »